TEROL LA (Detrol LA)4 mg – 30 tablet

$33.50

Each Terol La contains 4 mg Tolterodine 30 tablets a box, it is a treatment for an overactive bladder characterized by frequent urination.

ATC Classification: G04BD07
Active Ingrediant: Tolterodine Tartrate
Generic Name: TEROL LA
Manufacturer: Cipla Limited
Strength: 4 mg
Dosage Type: Capsule
Packaging Type: Foil in Box
Contains: 30 Cap

Examples of Packages sent

Free worldwide shipping on all orders over $50

  • 30 days easy returns
  • Order yours before 2.30pm for same day dispatch
Guaranteed Safe Checkout

Placeholder
TEROL LA (Detrol LA)4 mg – 30 tablet
$33.50

[wpforms id=”1190″ title=”true” description=”Request a call back”]

Tolterodine Tartrate Information


Pronunciation

tole TER oh deen

 

What is this drug used for?

• It is used to treat an overactive bladder.

Frequently reported side effects of this drug

• Dizziness

• Fatigue

• Headache

• Abdominal pain

• Constipation

• Dry mouth

• Dry eyes

Other side effects of this drug: Talk with your doctor right away if you have any of these signs of:

• Unable to pass urine

• Vision changes

• Signs of a significant reaction like wheezing; chest tightness; fever; itching; bad cough; blue skin color; seizures; or swelling of face, lips, tongue, or throat.

 

Medication Safety Issues

Sound-alike/look-alike issues:

Tolterodine may be confused with fesoterodine, tolcapone

Detrol may be confused with Ditropan

Geriatric Patients: High-Risk Medication:

Beers Criteria: Tolterodine is identified in the Beers Criteria as a potentially inappropriate medication in patients 65 years and older due to its strong anticholinergic properties (Beers Criteria [AGS 2019]).

 

Storage and Stability

Store at 25°C (77°F); excursions permitted to 15°C to 30°C (59°F to 86°F). Protect from light.

 

Adverse Reactions

As reported with immediate release tablet, unless otherwise specified.

Cardiovascular: Chest pain

Central nervous system: Anxiety (extended release capsules), dizziness (immediate and extended release), drowsiness (immediate and extended release), fatigue (immediate and extended release), headache (immediate and extended release)

Dermatologic: Xeroderma

Endocrine & metabolic: Weight gain

Gastrointestinal: Abdominal pain (immediate and extended release), constipation (immediate and extended release), diarrhea, dyspepsia (immediate and extended release), xerostomia (more common with immediate release tablets)

Genitourinary: Dysuria (immediate and extended release)

Infection: Infection

Neuromuscular & skeletal: Arthralgia

Ophthalmic: Xerophthalmia (immediate and extended release), visual disturbance (immediate and extended release)

Respiratory: Bronchitis, flu-like symptoms, sinusitis (extended release)

Rare but important or life-threatening: Anaphylaxis, angioedema, confusion, dementia (aggravated), disorientation, hallucination, memory impairment, palpitations, peripheral edema, prolonged Q-T interval on ECG, tachycardia –

Additional information

Active Ingrediant

Generic Name

Alternate Names

, , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , ,

Strength

Dosage Type

Packaging Type